CD8A and neoplasm: We had shown previously that AdT/CpG therapeutic efficacy was dependent upon CD8+ T cells in this tumor model [32] and that our combinatorial AdT/CpG+αCTLA-4 therapy induced a robust CD8+ TIL response in lean mice that responded well to therapy (Figure 1C).